在皮肤黑色素瘤中器官特定的微环境MR1表达
Patricia B Gordon1, Woong Young So1, Udochi F Azubuike1
1National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
bioRxiv : the preprint server for biology
|February 5, 2024
概括
转移性黑色素瘤细胞表现出器官特异性免疫逃避和改变的新陈代谢. 向与MHC I类相关的分子MR1可能为改善转移中的抗瘤免疫提供新的治疗策略.
科学领域:
- 免疫学 免疫学 免疫学
- 癌症生物学 癌症生物学
- 代谢成像 - 代谢成像
背景情况:
- 瘤微环境极大地影响免疫细胞活动和转移.
- 定制免疫反应以对抗转移性疾病需要理解器官特异性线索.
- 通过免疫媒介消除转移需要考虑这些微环境因素.
研究的目的:
- 研究黑色素瘤转移中的特定器官免疫细胞贩运和新陈代谢.
- 探索MHC复合体在不同转移部位内的免疫逃避中的作用.
- 为了将免疫反应与转移性病变中的代谢变化相关联.
主要方法:
- 利用成年斑马鱼黑色素瘤转移的异种移植模型.
- 采用静脉成像和光终身成像显微镜 (FLIM) 来同时可视化免疫细胞和新陈代谢.
- 在转移性病变中分析了MHC I类相关分子MR1 (mhc1uba) 的器官特异表达.
主要成果:
- 在脑和骨转移中的黑色素瘤细胞和免疫细胞上识别了MR1 (mhc1uba) 的特定器官表达.
- 在免疫能力强的鱼类的大脑转移性病变内的免疫群中观察到MR1 (mhc1uba) 表达的缺乏.
- 与骨转移相比,在脑转移中显示瘤糖解的增加,与差异性免疫反应有关.
结论:
- 这项研究强调了黑色素瘤转移中的器官特异性免疫逃避机制.
- 不同的免疫反应与瘤的器官特异性代谢重编程相关.
- 结果表明MR1是增强抗瘤免疫力和转移性环境中的药物疗效的潜在治疗标.
相关概念视频
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
MAPK Signaling Cascades
5.5K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.5K


